Search results for: “Biopharmaceutical”
-
Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion
•
Bristol Myers Squibb (BMY) announced today that it has agreed to acquire Karuna Therapeutics (KRTX), a biopharmaceutical company…
-
MaxCyte names Maher Masoud new CEO as Doug Doerfler retires after 24 years
•
LONDON, UK: MaxCyte, Inc., a leading cell-engineering company, announced today that Maher Masoud will take over as President…
-
AstraZeneca signs deal to acquire Icosavax Inc. for $1.1 billion
•
LONDON, UK: AstraZeneca has entered into a definitive agreement to acquire Icosavax Inc. (NASDAQ: ICVX), a US-based clinical-stage…
-
Elixirr International has acquired Insigniam LLC and Insigniam SAS for $18.5 million
•
LONDON, UK: Elixirr International’s US subsidiary Elixirr Inc. announced the acquisition of all of the issued and outstanding…
-
Merck signs $610 million deal to acquire Caraway Therapeutics
•
LONDON, UK: Merck, a global leader in biopharmaceuticals, has announced that it has entered into a definitive agreement…
-
Schroders Capital Global Innovation Trust makes investment in Memo Therapeutics
•
LONDON: Schroders Capital Global Innovation Trust has made a commitment of CHF 0.9 million (£0.8 million) to Memo…
-
Starpharma Holdings appoints Cheryl Maley as Chief Executive Officer and Managing Director
•
MELBOURNE, AUSTRALIA: Starpharma Holdings (ASX: SPL) announced the appointment of Ms Cheryl Maley as Chief Executive Officer (CEO)…
-
Poolbeg Pharma partners with a Nasdaq-Listed biopharma company
•
LONDON, UK: Poolbeg Pharma, a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, has signed…
-
AI drug developer Deep Genomics appoints Brian O’Callaghan as CEO
•
Deep Genomics, a company that uses AI to develop new medicines, has appointed Brian O’Callaghan as its new…
-
Nestlé divests its Palforzia business to Stallergenes Greer
•
LONDON, UK: Nestlé announced today that is has divested Palforzia, its peanut allergy treatment business, to Stallergenes Greer,…
-
Sanofi announces changes to its Executive Committee
•
PARIS, FRANCE: Sanofi, a global biopharmaceutical company, announced today the appointment of three new members to its Executive…
-
OCTP announces breakthrough in cancer immunotherapy
•
LONDON, UK: Oxford Cannabinoid Technologies Holdings plc (OCTP), a leading pharmaceutical company in the field of cannabinoid medicines,…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.